ABSTRACT
This Practical Guidance for Clinical Microbiology document on the laboratory diagnosis of parasites from the gastrointestinal tract provides practical information for the recovery and identification of relevant human parasites. The document is based on a comprehensive literature review and expert consensus on relevant diagnostic methods. However, it does not include didactic information on human parasite life cycles, organism morphology, clinical disease, pathogenesis, treatment, or epidemiology and prevention. As greater emphasis is placed on neglected tropical diseases, it becomes highly probable that patients with gastrointestinal parasitic infections will become more widely recognized in areas where parasites are endemic and not endemic. Generally, these methods are nonautomated and require extensive bench experience for accurate performance and interpretation.
Subject(s)
Clinical Laboratory Techniques , Gastrointestinal Diseases/diagnosis , Gastrointestinal Diseases/parasitology , Gastrointestinal Tract/parasitology , Parasitic Diseases/diagnosis , Parasitic Diseases/parasitology , HumansABSTRACT
Dientamoeba fragilis is a single-celled protozoan, closely related to the trichomonads. Reported worldwide as causing human gastrointestinal symptoms, D. fragilis is very common and is second only to Blastocystis spp. Dientamoebiasis equals or exceeds the incidence of giardiasis. This minireview includes diagnostic options, clinical relevance, therapy, an animal model, the confirmed cyst stage, and sequencing data. The development of a rodent model, fulfilling Koch's postulates, and the confirmation of a cyst stage have clarified transmission routes, including fecal-oral transmission. The prevalence of D. fragilis varies between 0% to over 82%; results depend on the geographic location, group studied, and diagnostic methods used.
Subject(s)
Dientamoeba/isolation & purification , Dientamoebiasis/epidemiology , Intestinal Diseases, Parasitic/epidemiology , Neglected Diseases/epidemiology , Animals , Antiprotozoal Agents/therapeutic use , Dientamoebiasis/diagnosis , Dientamoebiasis/drug therapy , Dientamoebiasis/pathology , Disease Models, Animal , Humans , Incidence , Intestinal Diseases, Parasitic/diagnosis , Intestinal Diseases, Parasitic/drug therapy , Intestinal Diseases, Parasitic/pathology , Neglected Diseases/diagnosis , Neglected Diseases/drug therapy , Neglected Diseases/pathology , PrevalenceABSTRACT
Malaria has had a greater impact on world history than any other infectious disease. More than 300 to 500 million individuals worldwide are infected with Plasmodium spp, and 1.5 to 2.7 million people a year, most of whom are children, die from the infection. Malaria is endemic in over 90 countries in which 2400 million people live; this represents 40% of the world's population. Approximately 90% of malaria deaths occur in Africa. Despite continuing efforts in vaccine development, malaria prevention is difficult, and no drug is universally effective. This article examines malaria caused by the 4 most common Plasmodium spp that infect humans, P vivax, P ovale, P malariae, and P falciparum, as well as mixed infections and the simian parasite P knowlesi. A comprehensive review of the microbiology, clinical presentation, pathogenesis, diagnosis, and treatment of these forms of malaria is given.
Subject(s)
Malaria/diagnosis , Plasmodium , Animals , Drug Resistance , Global Warming , Humans , Malaria/drug therapy , Malaria/epidemiology , Malaria/prevention & control , Malaria Vaccines/immunology , Parasitemia/diagnosis , Plasmodium/classification , Plasmodium/drug effects , Plasmodium/immunology , Plasmodium/isolation & purification , PrognosisABSTRACT
The SIMPLE-READ Giardia rapid assay (Medical Chemical Corporation) is a solid-phase qualitative immunochromatographic assay that detects Giardia lamblia in aqueous extracts of human fecal specimens. Testing 106 Giardia-positive and 104 Giardia-negative stool specimens yielded a sensitivity of 97.2% and a specificity of 100% for the SIMPLE-READ Giardia rapid assay.
Subject(s)
Antigens, Protozoan/analysis , Chromatography, Affinity/methods , Feces/parasitology , Giardia lamblia/chemistry , Giardiasis/diagnosis , Animals , Antigens, Protozoan/immunology , Giardia lamblia/isolation & purification , Humans , Sensitivity and SpecificityABSTRACT
We describe a U.S. Army Ranger returning from duty in Afghanistan and Iraq with life-threatening infection due to Plasmodium vivax. Morphological variants were observed in blood films prepared using samples collected by venipuncture. The patient's multiple relapses indicate infection with primaquine-tolerant P. vivax. Strategies for relapse prevention using primaquine are reviewed.
Subject(s)
Antimalarials , Drug Resistance , Malaria, Vivax/diagnosis , Malaria, Vivax/drug therapy , Military Personnel , Plasmodium vivax/drug effects , Primaquine , Adult , Animals , Antimalarials/administration & dosage , Antimalarials/pharmacology , Antimalarials/therapeutic use , Chemoprevention , Humans , Malaria, Vivax/parasitology , Malaria, Vivax/prevention & control , Male , Parasitemia/diagnosis , Parasitemia/drug therapy , Parasitemia/parasitology , Parasitemia/prevention & control , Plasmodium vivax/isolation & purification , Primaquine/administration & dosage , Primaquine/pharmacology , Primaquine/therapeutic use , Secondary PreventionABSTRACT
Parasitic infections are felt by most individuals to have little impact on the health and well being of most inhabitants of Canada, Western Europe, and the United States. As the authors show in this article, parasites are always "emerging" somewhere and have a significant impact on those areas of the world. Moreover, as we are becoming an ever-smaller global village, catastrophes and instability in the Third World affect control of parasitic diseases endemic to those areas, ensuring greater chances of transmission to visitors there. The foundation of successful limitation of parasitic diseases in both developing and developed regions is still accurate and rapid diagnosis.
Subject(s)
Communicable Diseases, Emerging/parasitology , Parasitic Diseases/epidemiology , Parasitic Diseases/parasitology , Humans , IncidenceABSTRACT
The ImmunoCard STAT! Cryptosporidium/Giardia rapid assay (Meridian Bioscience, Inc.) is a solid-phase qualitative immunochromatographic assay that detects and distinguishes between Giardia lamblia and Cryptosporidium parvum in aqueous extracts of human fecal specimens (fresh, frozen, unfixed, or fixed in 5 or 10% formalin or sodium acetate-acetic acid-formalin). By using specific antibodies, antigens specific for these organisms are isolated and immobilized on a substrate. After the addition of appropriate reagents, a positive test is detected visually by the presence of a gray-black color bar (regardless of the intensity) next to the organism name printed on the test device. A control is included in the device. Steps include tube preparation (buffer, patient specimen, conjugates A and B), testing (addition of sample onto the test device), and visual reading (total time, 12 min). Test performance was evaluated with known positive and negative stool specimens (170 specimens positive for Giardia and 231 specimens negative for Giardia) (85 specimens positive for Cryptosporidium and 316 specimens negative for Cryptosporidium); they were tested with trichrome, iron-hematoxylin, or modified acid-fast stains or the Meridian Bioscience, Inc., Giardia/Cryptosporidium Merifluor combination reagent; specimens with discrepant results were retested by using the Merifluor combination reagent. On the basis of the results of the reference methods, the sensitivities, specificities, and positive and negative predictive values were as follows: for G. lamblia, 93.5, 100, 100, and 95.5%, respectively; for C. parvum, 98.8, 100, 100, and 99.7%, respectively. False-negative results for G. lamblia were obtained with specimens with low parasite numbers (n = 7) or specimens containing trophozoites only (n = 3); one specimen with a false-negative result contained numerous cysts. The one specimen false negative for C. parvum was confirmed to be positive by immunofluorescence. No cross-reactivity was seen with 10 different protozoa (152 challenges), nine different helminths (35 challenges), or human cells (4 challenges) found in fecal specimens. This rapid test system may be very beneficial in the absence of trained microscopists; however, for patients who remain symptomatic after a negative result, the ova and parasite examination and special stains for other coccidia and the microsporidia should always remain options.
Subject(s)
Cryptosporidium parvum/isolation & purification , Feces/microbiology , Giardia lamblia/isolation & purification , Animals , Chromatography , Humans , Reagent Kits, DiagnosticABSTRACT
The in vitro culture of protozoan parasites involves highly complex procedures, which are subject to many variables. These parasites have very complex life cycles and, depending on the life cycle stage, may require different culture parameters. However, in vitro cultivation is important for many reasons, some of which include: diagnosis, antigen and antibody production, assessment of parasite immune modulating capabilities, drug screening, improvements in chemotherapy, differentiation of clinical isolates, determination of strain differences, vaccine production, development of attenuated strains, and the continued supply of viable organisms for studying host-parasite interactions.